PragmaTIL | Kick-off meeting

June 6, 2023

The launch of the EU-funded PragmaTIL project took place recently in Barcelona.

The PragmaTIL trial aims to optimize treatment of cancer patients with Tumour-Infiltrating Lymphocytes Adoptive Cell Therapy (TIL-ACT) and substantially expand and improve the clinical implementation of this treatment modality in academic hospitals. To this end, treatment related toxicities, associated to high-dose interleukin 2 (HD-IL-2) required for expansion and activation of TILs will be reduced while maintaining efficacy.

This improved tolerability will achieve a better clinical management of patients and enhance their quality of life, both of which represent major barriers for applying this treatment.

Asphalion will be in charge of the Regulatory part of the project, focusing on the submission of the clinical trial and the safety management plan.

Stay tuned for updates!

For further information, you can contact us at: info@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

NABIHEAL project | Progress meeting

ASPHALION is proud member of the NABIHEAL EU-funded project consortium, ensuring the compliance with regulatory standards during the pre-clinical development of the innovative NABIHEAL product development to facilitate future fast translation to clinical setting

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting